These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 2594826)

  • 21. Dissolution studies on tablets of ibuprofen using chitosan.
    Ilango R; Kavimani S; Jaykar B; Umamaheshwari G
    Indian J Exp Biol; 1999 May; 37(5):505-8. PubMed ID: 10492622
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Preparation and in vitro evaluation of chitosan matrices for colonic controlled drug delivery.
    Zambito Y; Di Colo G
    J Pharm Pharm Sci; 2003; 6(2):274-81. PubMed ID: 12935439
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Direct compression of chitosan: process and formulation factors to improve powder flow and tablet performance.
    Buys GM; du Plessis LH; Marais AF; Kotze AF; Hamman JH
    Curr Drug Deliv; 2013 Jun; 10(3):348-56. PubMed ID: 23545146
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In-vitro and in-vivo studies of the diclofenac sodium controlled-release matrix tablets.
    Liu CH; Kao YH; Chen SC; Sokoloski TD; Sheu MT
    J Pharm Pharmacol; 1995 May; 47(5):360-4. PubMed ID: 7494183
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Preparation and evaluation of chitosan/carrageenan beads for controlled release of sodium diclofenac.
    Piyakulawat P; Praphairaksit N; Chantarasiri N; Muangsin N
    AAPS PharmSciTech; 2007 Nov; 8(4):E97. PubMed ID: 18181557
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sustained release tablets based on chitosan and carboxymethylcellulose sodium.
    Inouye K; Machida Y; Nagai T
    Drug Des Deliv; 1987 May; 1(4):297-305. PubMed ID: 3509339
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Preparation and evaluation of sodium diclofenac controlled-release tablets. II. Dibasic calcium phosphate as a retardant in mixtures for direct compression.
    Lin SY; Cheng CL; Lin PC
    Pharm World Sci; 1995 Mar; 17(2):42-7. PubMed ID: 7795557
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Report: in vitro dissolution studies of different brands of sustained release diclofenac sodium matrix tablet available in Bangladesh.
    Abdullah MD; Bepary S; Rouf AS
    Pak J Pharm Sci; 2008 Jan; 21(1):70-7. PubMed ID: 18166523
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dissolution parameters for sodium diclofenac-containing hypromellose matrix tablet.
    Mourão SC; da Silva C; Bresolin TM; Serra CH; Porta V
    Int J Pharm; 2010 Feb; 386(1-2):201-7. PubMed ID: 19941944
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluation of Mimosa pudica seed mucilage as sustained-release excipient.
    Singh K; Kumar A; Langyan N; Ahuja M
    AAPS PharmSciTech; 2009; 10(4):1121-7. PubMed ID: 19763837
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In vitro release of sodium diclofenac from a central core matrix tablet aimed for colonic drug delivery.
    González-Rodríguez ML; Maestrelli F; Mura P; Rabasco AM
    Eur J Pharm Sci; 2003 Sep; 20(1):125-31. PubMed ID: 13678801
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sustained-release of oxytetracycline from chitosan microspheres prepared by interfacial acylation and spray hardening methods.
    Mi FL; Wong TB; Shyu SS
    J Microencapsul; 1997; 14(5):577-91. PubMed ID: 9292434
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The influence of formulation on the dissolution profile of diclofenac sodium tablets.
    De Castro WV; Pires MA; Oliveira MA; Vianna-Soares CD; Nunan EA; Pianetti GA; Moreira-Campos LM; De Castro WV; Mertens-Talcott SU; Derendorf H
    Drug Dev Ind Pharm; 2006 Oct; 32(9):1103-9. PubMed ID: 17012123
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Release of poorly soluble drugs from HPMC tablets studied by FTIR imaging and flow-through dissolution tests.
    van der Weerd J; Kazarian SG
    J Pharm Sci; 2005 Sep; 94(9):2096-109. PubMed ID: 16052556
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Sustained-release effect of the direct compressed tablet based on chitosan and Na alginate].
    Yomota C; Miyazaki T; Okada S
    Yakugaku Zasshi; 1994 Apr; 114(4):257-63. PubMed ID: 8201547
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Soluble filler as a dissolution profile modulator for slightly soluble drugs in matrix tablets.
    Dvorácková K; Rabisková M; Masteiková R; Muselík J; Krejcová K
    Drug Dev Ind Pharm; 2009 Aug; 35(8):930-40. PubMed ID: 19274510
    [TBL] [Abstract][Full Text] [Related]  

  • 37. RELEASE AND MUCOADHESION PROPERTIES OF DICLOFENAC MATRIX TABLETS FROM NATURAL AND SYNTHETIC POLYMER BLENDS.
    Odeniyi MA; Khan NH; Peh KK
    Acta Pol Pharm; 2015; 72(3):559-67. PubMed ID: 26642664
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Two- and three-layer tablet drug delivery systems for oral sustained release of soluble and poorly soluble drugs.
    Efentakis M; Naseef H; Vlachou M
    Drug Dev Ind Pharm; 2010 Aug; 36(8):903-16. PubMed ID: 20196641
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Formulation, evaluation and in vitro characterization of gastroretentive floating tablet of diclofenac sodium.
    Shehzad MQ; Nazir T; Nazir SU; Taha N; Jamil T; Akram MA
    Pak J Pharm Sci; 2019 Nov; 32(6):2573-2578. PubMed ID: 31969288
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Study of the prolonged release of theopylline from polymeric matrices based on grafted chitosan with acrylamide.
    Tapia C; Costa E; Terraza C; Munita AM; Yazdani-Pedram M
    Pharmazie; 2002 Nov; 57(11):744-9. PubMed ID: 12611277
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.